Saturday, August 2, 2025

Latest

Tilray: Haywood Expects Canadian Market Share To Drop In First Quarter

Tilray Inc (TSX: TLRY) (NASDAQ: TLRY) announced that they would be reporting their Fiscal first-quarter results of 2021 on October 7th, this will be for the period ending August 31st. Ahead of this date, Haywood released a note outlining their estimates and gave a general preview.

Tilray currently has 20 analysts covering the stock with an average 12-month price target of U$15.72. Out of the 20 analysts, 2 have strong buy ratings, 3 have buys, 13 have holds and 2 have sell ratings. The street high comes in at U$27 while the lowest price target sits at U$1.27.

In Haywood’s note, they reiterate their hold rating but lower their 12-month price target on Tilray to $13.50 from $16.50. This quarter will be the first full quarter that shows the combination between Tilray and Aphria, Haywood is hoping that this quarter will show off the “synergistic value created in terms of both cost savings and revenue growth.” They also expect the earnings call to be heavily weighted toward the outlook of the companies individual segments as well as its recent Medmen Enterprises (CSE: MMEN) deal.

For the quarter ending August 31st, Haywood is expecting net revenues of $171.5 million, effectively 21% sequential growth. This is slightly below the $174.23 million consensus estimate. Gross margin for the quarter is expected to be just shy of 30% at 29.7%, slightly higher than the consensus. They expect adjusted EBITDA to come in at a pitiful $8.5 million, or a 5% EBITDA margin.

With the price target lowered, they have slightly lowered their 2022 and 2023 estimates. They say that they are lowering revenue estimates based on lower Canadian adult-use market share, as well as COVID-19 headwinds in the company’s international segments. Management noted that floods in Germany will impact CC Pharma’s first-quarter revenue and margins.

Haywood says that even after changing Tilray’s market share percent, they remain the market leader in Canada, but they “remain cautious on the overall Canadian landscape which drives the majority of its revenue growth opportunity in the near term.”


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Royal Gold Goes Big | $3.5 Billion Sandstorm Acquisition

Why Gold’s Bull Run May Just Be Getting Started! | Peter Grandich

Tariffs Spark New Race for Critical Metals | Rob McEwen

Recommended

Tsunami Warnings Spread As Largest Quake Since 2011 Hits Russia

Northern Superior Intersects 1.75 g/t Gold Over 65.0 Metres At Philibert

Related News

TerrAscend: Canaccord Initiates Coverage With $4.25 Price Target, Buy Rating

On September 12, Canaccord Genuity initiated coverage on TerrAscend Corp (CSE: TER) with a buy...

Saturday, September 17, 2022, 05:17:00 PM

Ayr Wellness: Canaccord Raises Price Target To $70

On March 10th, Ayr Wellness (CSE: AYR.a) reported their fourth quarter and year end financial...

Sunday, March 14, 2021, 02:41:00 PM

Equinox Gold: Mercedes Mine Sale Was “A Favourable Sale Price For A Non-Core Asset”

On December 17th, Equinox Gold (TSX: EQX) announced that they reached an agreement to sell...

Sunday, December 26, 2021, 02:14:00 PM

Royal Caribbean Cruises: Analysts Expect Q4 Loss Per Share Of $4.39

Royal Caribbean Cruises (NYSE: RCL) will be reporting their second quarter financial results before the...

Tuesday, August 3, 2021, 05:36:00 PM

Trican Well Service: Consensus Price Target Rises To $3.26

On July 27, Trican Well Service (TSX: TCW) reported their second-quarter financials. The company reported...

Sunday, August 1, 2021, 12:06:00 PM